Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-05-13 @ 6:59 PM
Study NCT ID:
NCT01225302
Status:
COMPLETED
Last Update Posted:
2017-11-21
First Post:
2010-09-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
AbbVie
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
W12-076
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None